PreprintCited by 13Pharmaceutical and Antibiotic Environmental ImpactsEnzyme Structure and FunctionEnzyme Catalysis and Immobilization

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Discovery of a unique Ni2+-dependent heterohexameric metformin hydrolase

Open access
Zhou, Ning-Yi, Li, Tao, Xu, Zhi-Jing, Zhang, Shu-Ting, Xu, Jia, Pan, Piao-Piao·2024·Nature Communications

Preprint — published as 10.1038/s41467-024-50409-7 · Paper page

Abstract

The biguanide drug metformin is prescribed worldwide as a first-line blood glucose-lowering medication for type 2 diabetes, leading to its presence in the environment around the world. Despite mounting evidence indicating that metabolic interactions of metformin with environmental or intestinal microbes affect ecological and human health, little is known about the fate of metformin by microbial catabolism. Here, we characterized a Ni 2+-dependent bacterial enzyme that catalyzes the hydrolysis of metformin to form guanylurea and dimethylamine. The metformin hydrolase MetCaCb is a heterohexamer with an uneven α 2 β 4 stoichiometry. Both subunits are from the arginase protein family, members of which are typically homomultimers. Either subunit alone is catalytically inactive, but together they work as an active enzyme highly specific for metformin. The crystal structure of the MetCaCb complex clearly shows the coordination of the binuclear metal cluster only in MetCa, following a geometry typical for arginase family enzymes. A unique pseudoenzyme MetCb, which evolved without a binuclear metal cluster, contributes to hydrolase activity as a protein binder of its active cognate. An in-silico search and functional assay led to the discovery of a group of MetCaCb-like protein pairs exhibiting metformin hydrolase activity in the environment. Our findings not only establish the genetic and biochemical foundation for metformin catabolism but also provide new insights into the adaption of the ancient arginase family proteins toward newly occurred substrate.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.21203/rs.3.rs-3656883/v1

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 48

  1. Dos SGR et al (2022) Medicines as an emergent contaminant: the review of microbial biodegration potential. Folia Microbiol (Praha) 67:157–174 · DOI
  2. Wilkinson JL et al (2022) Pharmaceutical pollution of the world's rivers. Proc. Natl. Acad. Sci. U S A 119, e2113947119
  3. Lindell AE, Zimmermann-Kogadeeva M, Patil KR (2022) Multimodal interactions of drugs, natural compounds and pollutants with the gut microbiota. Nat Rev Microbiol 20:431–443 · DOI
  4. Zimmermann M, Zimmermann-Kogadeeva M, Wegmann R, Goodman AL (2019) Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature 570:462–467 · DOI · Paper page
  5. Werner EA, Bell J (1922) CCXIV.—The preparation of methylguanidine, and of ββ-dimethylguanidine by the interaction of dicyanodiamide, and methylammonium and dimethylammonium chlorides respectively. J Chem Soc Trans 121:1790–1794 · DOI
  6. Foretz M, Guigas B, Viollet B (2023) Metformin: update on mechanisms of action and repurposing potential. Nat Rev Endocrinol 19:460–476 · DOI
  7. Balakrishnan A, Sillanpää M, Jacob MM, Vo DN (2022) Metformin as an emerging concern in wastewater: Occurrence, analysis and treatment methods. Environ Res 213:113613 · DOI
  8. Elizalde-Velazquez GA, Gomez-Olivan LM (2020) Occurrence, toxic effects and removal of metformin in the aquatic environments in the world: Recent trends and perspectives. Sci Total Environ 702:134924 · DOI
  9. Cabreiro F et al (2013) Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism. Cell 153:228–239 · DOI · Paper page
  10. Forslund K et al (2015) Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528:262–266. 10.1038/nature15766 · DOI · Paper page
  11. He Y, Zhang Y, Ju F (2022) Metformin contamination in global waters: biotic and abiotic transformation, byproduct generation and toxicity, and evaluation as a pharmaceutical indicator. Environ Sci Technol 56:13528–13545 · DOI
  12. Briones RM, Zhuang WQ, Sarmah AK (2018) Biodegradation of metformin and guanylurea by aerobic cultures enriched from sludge. Environ Pollut 243:255–262 · DOI
  13. Poursat BAJ et al (2019) Biodegradation of metformin and its transformation product, guanylurea, by natural and exposed microbial communities. Ecotox Environ Saf 182:109414 · DOI
  14. Tassoulas LJ, Robinson A, Martinez-Vaz B, Aukema KG, Wackett LP (2021) Filling in the gaps in metformin biodegradation: a new enzyme and a metabolic pathway for guanylurea. Appl Environ Microbiol 87:e03003–e03020 · DOI
  15. Martinez-Vaz BM et al (2022) Wastewater bacteria remediating the pharmaceutical metformin: Genomes, plasmids and products. Front Bioeng Biotechnol 10:1086261 · DOI
  16. Li T, Xu Z-J, Zhou N-Y (2023) Aerobic Degradation of the antidiabetic drug metformin by Aminobacter sp. strain NyZ550. Environ Sci Technol 57:1510–1519 · DOI
  17. Chaignaud P et al (2022) A Methylotrophic bacterium growing with the antidiabetic drug metformin as its sole carbon, nitrogen and energy source. Microorganisms 10:2302 · DOI
  18. Hillmann KB, Niehaus TD (2022) Genome sequences of two Pseudomonas isolates that can use metformin as the sole nitrogen source. Microbiol Resour Announc 11:e0063922 · DOI
  19. Hernández VM, Arteaga A, Dunn MF (2021) Diversity, properties and functions of bacterial arginases. FEMS Microbiol Rev 45:fuab034 · DOI
  20. Baggio R et al (1997) Inhibition of Mn2 + 2-arginase by borate leads to the design of a transition state analogue inhibitor, 2(S)-amino-6-boronohexanoic acid. J Am Chem Soc 119:8107–8108 · DOI
  21. Di Costanzo L et al (2005) Crystal structure of human arginase I at 1.29-Å resolution and exploration of inhibition in the immune response. Proc. Natl. Acad. Sci. U S A 102, 13058–13063
  22. Velázquez-Libera JL, Caballero J, Tuñón I, Hernández-Rodríguez EW, Ruiz-Pernía JJ (2020) On the nature of the enzyme–substrate complex and the reaction mechanism in human arginase I. A combined molecular dynamics and QM/MM study. ACS Catal 10:8321–8333 · DOI
  23. O'Leary N et al (2015) Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation. Nucleic Acids Res 44:D733–D745 · DOI · Paper page
  24. Miller D, Xu H, White RH (2012) A new subfamily of agmatinases present in Methanogenic Archaea Is Fe(II) dependent. Biochemistry 51:3067–3078 · DOI
  25. Saragadam T, Kumar S, Punekar N (2019) Characterization of 4-guanidinobutyrase from Aspergillus niger. Microbiology 165:396–410 · DOI
  26. Arakawa N, Igarashi M, Kazuoka T, Oikawa T, Soda K (2003) D-arginase of Arthrobacter sp. KUJ 8602: characterization and its identity with Zn2+-guanidinobutyrase. J biochem 133:33–42 · DOI
  27. McGee D et al (2004) Purification and characterization of Helicobacter pylori arginase, RocF: unique features among the arginase superfamily. Eur J biochem 271:1952–1962 · DOI · Paper page
  28. Funck D et al (2022) Discovery of a Ni2+-dependent guanidine hydrolase in bacteria. Nature 603:515–521 · DOI
  29. Romero N et al (2017) Mammalian agmatinases constitute unusual members in the family of Mn2+-dependent ureahydrolases. J Inorg Biochem 166:122–125 · DOI
  30. Hai Y, Kerkhoven EJ, Barrett MP, Christianson DW (2015) Crystal structure of an arginase-like protein from Trypanosoma brucei that evolved without a binuclear manganese cluster. Biochemistry 54:458–471 · DOI
  31. Mothersole RG et al (2022) Sequence divergence in the arginase domain of ornithine decarboxylase/arginase in Fusobacteriacea leads to loss of function in oral associated species. Biochemistry 61:1378–1391 · DOI
  32. Garcia D, Uribe E, Salgado M, Martínez M (2014) Mutagenic and kinetic support for an allosteric site in arginase from the extreme thermophile Bacillus caldovelox, which allows activation by arginine. Biochimie 108:8–12 · DOI
  33. Lobos M et al (2020) Insights on the participation of Glu256 and Asp204 in the oligomeric structure and cooperative effects of human arginase type I. J Struct Biol 211:107533 · DOI
  34. Lavulo L et al (2001) Subunit-subunit interactions in trimeric arginase. Generation of active monomers by mutation of a single amino acid. J biol Chem 276:14242–14248 · DOI
  35. Adrain C, Freeman M (2012) New lives for old: evolution of pseudoenzyme function illustrated by iRhoms. Nat rev Mol cell biol 13:489–498 · DOI
  36. Schneider NO et al (2020) Solving the conundrum: widespread proteins annotated for urea metabolism in bacteria are carboxyguanidine deiminases mediating nitrogen assimilation from guanidine. Biochemistry 59:3258–3270 · DOI
  37. Fida TT, Palamuru S, Pandey G, Spain JC (2014) Aerobic biodegradation of 2,4-dinitroanisole by Nocardioides sp. strain JS1661. Appl Environ Microbiol 80:7725–7731 · DOI
  38. Balaich J et al (2021) The human microbiome encodes resistance to the antidiabetic drug acarbose. Nature 600:110–115 · DOI
  39. Tian J et al (2023) Inactivation of the antidiabetic drug acarbose by human intestinal microbial-mediated degradation. Nat Metab 5:1–14 · DOI
  40. Brown JB, Conner C, Nichols GA (2010) Secondary failure of metformin monotherapy in clinical practice. Diabetes Care 33:501–506 · DOI
  41. Liu H, Wang SJ, Zhou NY (2005) A new isolate of Pseudomonas stutzeri that degrades 2-chloronitrobenzene. Biotechnol Lett 27:275–278 · DOI
  42. Kabsch WXDS (2010) Acta Crystallogr D Biol Crystallogr 66:125–132 · DOI · Paper page
  43. McCoy A et al (2007) PHASER crystallographic software. J appl Crystallogr 40:658–674 · DOI · Paper page
  44. Adams P et al (2011) The Phenix software for automated determination of macromolecular structures. Methods (San Diego Calif) 55:94–106 · DOI
  45. Emsley P, Lohkamp B, Scott WG, Cowtan K (2010) Features and development of COOT. Acta Crystallogr D 66:486–501 · DOI · Paper page
  46. Williams CJ et al (2018) More and better reference data for improved all-atom structure validation. Protein Sci 27:293–315MolProbity · DOI · Paper page
  47. Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455–461 · DOI · Paper page
  48. Madeira F et al (2022) Search and sequence analysis tools services from EMBL-EBI in 2022. Nucleic acids res 50:W276–W279 · DOI

Metadata

Authors
Zhou, N.-Y., Li, T., Xu, Z.-J., Zhang, S.-T., Xu, J., & Pan, P.-P.
Affiliations
  • Shanghai Jiao Tong University (CN)
  • Shanghai Jiao Tong University
Corresponding author
Zhou, Ning-Yi
Venue
Nature Communications
Published
2024-01-31
Volume
15
Issue
1
Pages
6121-6121
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4400842703
Cited by
13
References
1
Citations by year
2026: 4 · 2025: 5 · 2024: 4
FWCI
1.30
Type
journal article
Language
en
Open access
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (32230001)
  • Ocean University of China
  • Shanghai Jiao Tong University
  • State Key Laboratory of Microbial Metabolism
  • School of Life Sciences and Biotechnology Division of Life Sciences, Korea University
Topics
  • Physical Sciences › Environmental Science › Pollution › Pharmaceutical and Antibiotic Environmental Impacts
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Enzyme Catalysis and Immobilization
Keywords
metformin, nickel-dependent enzymes, guanylurea, dimethylamine, type 2 diabetes drugs, environmental fate of pharmaceuticals, enzyme evolution, crystal structure
MeSH terms
Bacterial Proteins, Hydrolases, Hydrolysis, Metformin, Models, Molecular, Nickel, Substrate Specificity, Crystallography, X-Ray

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review